• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Dec 1982; 38(3): 1208–1216.
PMCID: PMC347877

Leishmaniasis in beige mice.

Abstract

The courses of two protozoal diseases, cutaneous and visceral leishmaniasis, were examined in three groups of C57BL/6J mice. One group of mice was homozygous recessive for the beige gene (bg/bg). Beige mice are the genetic homologue of the human Chédiak-Higashi syndrome and, among other defects, are profoundly deficient in natural killer cell activity. Wild-type (+/+) mice, which respond to experimental cutaneous or visceral leishmaniasis by eventually eliminating their parasites, and heterozygous beige (bg/+) mice served as controls; both are phenotypically normal in natural killer cell activity, which is particularly high in the spleen. In bg/bg mice, the course of Leishmania tropica, a causative agent of cutaneous leishmaniasis, was similar to that in control mice after both primary and challenge inoculations. All groups of mice expressed similar humoral and cellular immune responses to L. tropica antigen. However, bg/bg mice failed to eliminate amastigotes of Leishmania donovani, a causative agent of visceral leishmaniasis, from their spleens over an observation period of 56 days, in contrast to bg/+ and +/+ controls. Similar levels of anti-leishmanial antibody were produced by all groups of mice, and all mice responded comparably to footpad injections of L. donovani antigen. The results of this study suggest a possible role for natural killer cells in recovery from L. donovani but not from L. tropica infection.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alexander J, Vickerman K. Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages. J Protozool. 1975 Nov;22(4):502–508. [PubMed]
  • Blackwell J, Freeman J, Bradley D. Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature. 1980 Jan 3;283(5742):72–74. [PubMed]
  • Bradley DJ, Kirkley J. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice. Clin Exp Immunol. 1977 Oct;30(1):119–129. [PMC free article] [PubMed]
  • Buchmüller Y, Mauel J. Studies on the mechanisms of macrophage activation: possible involvement of oxygen metabolites in killing of Leishmania enrietti by activated mouse macrophages. J Reticuloendothel Soc. 1981 Mar;29(3):181–192. [PubMed]
  • Chang KP, Dwyer DM. Leishmania donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes. J Exp Med. 1978 Feb 1;147(2):515–530. [PMC free article] [PubMed]
  • DeTolla LJ, Scott PA, Farrell JP. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics. 1981;14(1-2):29–39. [PubMed]
  • Elin RJ, Edelin JB, Wolff SM. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect Immun. 1974 Jul;10(1):88–91. [PMC free article] [PubMed]
  • Eugui EM, Allison AC. Differences in susceptibility of various mouse strains to haemoprotozoan infections: possible correlation with natural killer activity. Parasite Immunol. 1980 Winter;2(4):277–292. [PubMed]
  • Hale C, Howard JG. Immunological regulation of experimental cutaneous leishmaniasis. 2. Studies with Biozzi high and low responder lines of mice. Parasite Immunol. 1981 Spring;3(1):45–55. [PubMed]
  • Handman E, Ceredig R, Mitchell GF. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci. 1979 Feb;57(1):9–29. [PubMed]
  • Hatcher FM, Kuhn RE, Cerrone MC, Burton RC. Increased natural killer cell activity in experimental American trypanosomiasis. J Immunol. 1981 Sep;127(3):1126–1130. [PubMed]
  • Herberman RB, Ortaldo JR. Natural killer cells: their roles in defenses against disease. Science. 1981 Oct 2;214(4516):24–30. [PubMed]
  • Hodgkinson VH, Herman R, Semprevivo L. Leishmania donovani: correlation among assays of amastigote viability. Exp Parasitol. 1980 Dec;50(3):397–408. [PubMed]
  • Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 1980 Winter;2(4):303–314. [PubMed]
  • James SL, Kipnis TL, Sher A, Hoff R. Enhanced resistance to acute infection with Trypanosoma cruzi in mice treated with an interferon inducer. Infect Immun. 1982 Feb;35(2):588–593. [PMC free article] [PubMed]
  • Kamiyama T, Hagiwara T. Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun. 1982 May;36(2):628–636. [PMC free article] [PubMed]
  • Leclerc C, Modabber F, Deriaud E, Cheddid L. Systemic infection of Leishmania tropica (major) in various strains of mice. Trans R Soc Trop Med Hyg. 1981;75(6):851–854. [PubMed]
  • Lewis DH, Peters W. The resistance of intracellular Leishmania parasites to digestion by lysosomal enzymes. Ann Trop Med Parasitol. 1977 Sep;71(3):295–312. [PubMed]
  • Mahoney KH, Morse SS, Morahan PS. Macrophage functions in beige (Chédiak-Higashi syndrome) mice. Cancer Res. 1980 Nov;40(11):3934–3939. [PubMed]
  • Murphy JW, McDaniel DO. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J Immunol. 1982 Apr;128(4):1577–1583. [PubMed]
  • Murray HW. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med. 1981 May 1;153(5):1302–1315. [PMC free article] [PubMed]
  • Roder JC. The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J Immunol. 1979 Nov;123(5):2168–2173. [PubMed]
  • Roder J, Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 1979 Mar 29;278(5703):451–453. [PubMed]
  • Roder JC, Lohmann-Matthes ML, Domzig W, Wigzell H. The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol. 1979 Nov;123(5):2174–2181. [PubMed]
  • Scott PA, Farrell JP. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg. 1982 Mar;31(2):230–238. [PubMed]
  • Shellam GR, Allan JE, Papadimitriou JM, Bancroft GJ. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5104–5108. [PMC free article] [PubMed]
  • Stauber LA. Characterization of strains of Leishmania donovani. Exp Parasitol. 1966 Feb;18(1):1–11. [PubMed]
  • Stutman O, Cuttito MJ. Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice. Nature. 1981 Mar 19;290(5803):254–257. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...